Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book

Jundishapur Journal of Microbiology

Ahvaz Jundishapur University of Medical Sciences

homeHome
play_arrowCurrent IssuelistAll Issuesformat_indent_increaseIn Presscheck_circleAccepted ManuscriptssearchSearch
lightbulbInstructions
infoJournal InformationgroupsEditors & BoardsshareIndexing and Listing Sourcesshow_chartJournal Metricszoom_inOpen Peer Review (OPR)balancePublication Ethics and Malpractice Statementassignment_indReviewer and AE Registration FormemailSupportphoneContact Us
format_list_bulletedAPC
Authors GuideSubmit Manuscript

Outlines

https://doi.org/10.5812/jjm.7214

Evidence of Hepatitis D Virus Infection in HBsAg Positive Subjects of Mashhad, North-East of Iran

Author(s):
Hosain NomaneeHosain Nomanee1, Sina RostamiSina Rostami2, Mohammad Taghi ShakeriMohammad Taghi Shakeri3, Zahra MeshkatZahra MeshkatZahra Meshkat ORCID1,*
1Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, IR Iran
2Department of Biology, Faculty of Sciences, Ferdowsi University of Mashhad, Mashhad, IR Iran
3Department of Biostatistics, Public Health School, Mashhad University of Medical Sciences, Mashhad, IR Iran
Jundishapur Journal of Microbiology:Vol. 8, issue 10; e7214
Published online:Oct 20, 2015
Article type:Letter
Received:Jul 11, 2012
Accepted:Sep 29, 2012
How to Cite:Nomanee H, Rostami S, Taghi Shakeri M, Meshkat Z. Evidence of Hepatitis D Virus Infection in HBsAg Positive Subjects of Mashhad, North-East of Iran. Jundishapur J Microbiol. 2015;8(10):e7214. doi: https://doi.org/10.5812/jjm.7214
Keywords
Hepatitis D Virus
HBsAg
Hepatitis B Virus

Dear Editor,
Anti-Hepatitis D Virus (HDV) among hepatitis B virus surface antigen (HBsAg) positive subjects has been reported from various countries such as Romania (1), Russia (2), Bangladesh (3), Pakistan (4), Saudi Arabia (5), Italy (6), and Mexico (7) with a prevalence of 83.3%, 12.5%, 24.4%, 16.6%, 8.6%, 8.3%, and 4%, respectively. According to studies carried out in Iran, HDV does not have a similar prevalence in different parts of the country. While the overall prevalence seems to have declined in Iran, studies demonstrated an upward trend of HDV infection prevalence among HBsAg-positive patients (8). As described previously, of 3198 individuals enrolled in this study, 34 were HBsAg positive (9). None of HBsAg-positive subjects were positive for anti-HDV.
Similar studies have been carried out in different parts of Iran and different prevalence rates have been reported. A study in Tehran, reported that HDV prevalence rate among Hepatitis B Virus (HBV) infected patients was 12.6% (10). Yaghob et al. observed HDV positivity in 2.2% of HBsAg blood donors in Shahrekord, West of Iran (11). In Golestan province, the prevalence was reported to be 5.8% (12). One study even noted a prevalence of 10.7% in Kerman (13), which is among one of the highest prevalence rates in Iran. In Tehran, capital of Iran, Rezvan et al. (14) noted anti-HDV Ab in 2.4% of HBsAg positive blood donors. According to previous studies in Iran, risk factors for becoming infected with HDV includes surgery, dentistry interventions, endoscopy, tattooing, war injury, traditional phlebotomy (Hejamat), and family history (15).
In our study, none of the HBsAg-positive subjects had positive results for anti-HDV. Since vaccination against HBV can also protect against HDV infection, the data of this study confirms the notion that expanded HBV vaccination coverage in our region might limit the spread of HDV in the normal population. Since HDV infection among HBV carriers could not be prevented unless by educating individuals to prevent further exposures, preventive measures such as vaccination against HBV is necessary but not sufficient for decreasing the prevalence (16). Further investigations with larger sample sizes seem essential to clarify risk factors and prevalence rates in our region.

Acknowledgments

Footnotes

References

  • 1.
    Tapalaga D, Forzani B, Hele C, Paravacini O, Ponzetto A, Theilmann L. Prevalence of the hepatitis delta virus in Rumania. Hepatogastroenterology. 1986;33(6):238-9. [PubMed ID: 3804180].
  • 2.
    Ivaniushina VA, Ryzhova EV, Grudinin MP, Katorgina LG, Nikonova AN, Vinogradova EN, et al. [The frequency of antibodies against delta virus in patients with HBs positive hepatitis]. Vopr Virusol. 1996;41(4):166-9. [PubMed ID: 8999671].
  • 3.
    Zaki H, Darmstadt GL, Baten A, Ahsan CR, Saha SK. Seroepidemiology of hepatitis B and delta virus infections in Bangladesh. J Trop Pediatr. 2003;49(6):371-4. [PubMed ID: 14725415].
  • 4.
    Mumtaz K, Hamid SS, Adil S, Afaq A, Islam M, Abid S, et al. Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan. J Gastroenterol Hepatol. 2005;20(10):1503-7. [PubMed ID: 16174065]. https://doi.org/10.1111/j.1440-1746.2005.03857.x.
  • 5.
    Al-Traif I, Ali A, Dafalla M, Al-Tamimi W, Qassem L. Prevalence of hepatitis delta antibody among HBsAG carriers in Saudi Arabia. Ann Saudi Med. 2004;24(5):343-4. [PubMed ID: 15573844].
  • 6.
    Gaeta GB, Stroffolini T, Chiaramonte M, Ascione T, Stornaiuolo G, Lobello S, et al. Chronic hepatitis D: a vanishing Disease? An Italian multicenter study. Hepatology. 2000;32(4 Pt 1):824-7. [PubMed ID: 11003629]. https://doi.org/10.1053/jhep.2000.17711.
  • 7.
    Munoz Espinosa LE, Ibarra Salas MJ. [Prevalence of hepatitis D in a population of Northeast Mexico and its relationship with other viruses]. Rev Gastroenterol Mex. 1997;62(4):246-9. [PubMed ID: 9580232].
  • 8.
    Shahinsaz L, Sabahi F, Karimi M, Behzadian F, Alavian SM, Zand V. Detection and genotyping of hepatitis D virus from HBsAg positive patients in Iran using RT-PCR. Iran J Biotech. 2006;4(3):174-9.
  • 9.
    Shakeri MT, Foghanian B, Nomani H, Ghayour-Mobarhan M, Nabavinia MS, Rostami S, et al. The prevalence of hepatitis B virus infection in Mashhad, Iran: a population-based study. Red Crescent Med J. 2013;15(3):245-8.
  • 10.
    Foroutan H, Nemati A, Nasiri-Tosi M, Ghofrani H, Keivani H. Prevalence of hepatitis delta virus infection in various groups with HBVinfection in Tehran, Imam Khomeini Hospital (2005-2006). Med J Islam Repub Iran. 2008;22(2):93-7.
  • 11.
    Yaghob R, Momeni M, Tajbakhsh F, Hamedi S. Serological survey of HDV-Ab in HBsAg positive blood donors in Shahrekord, Iran. Afr J Microbiol. 2011;5(10):1243-5.
  • 12.
    Roshandel G, Semnani S, Abdolahi N, Keshtkar AA, Besharat S, Joshaghani H, et al. Prevalence of hepatitis D virus infection in HBsAg positive subjects in Iran. Pak J Biol Sci. 2007;10(10):1751-4. [PubMed ID: 19086531].
  • 13.
    Zahedi M, Darvish-Moghaddam S, Zareei H. Clinical Impact and Frequency of Hepatitis D Virus Infection in HBsAg Positive Patients in a Southern Province of Iran (Kerman). Iran J Virol. 2010;3(2):1-6.
  • 14.
    Rezvan H, Forouzandeh B, Taroyan S, Fadaiee S, Azordegan F. A study on delta virus infection and its clinical impact in Iran. Infection. 1990;18(1):26-8. [PubMed ID: 2155876].
  • 15.
    Alavian SM, Alavian SH. Hepatitis D virus infection; Iran, Middle East and Central Asia. Hepat Mon. 2005;5(4):137.
  • 16.
    Abbas Z, Jafri W, Raza S. Hepatitis D: Scenario in the Asia-Pacific region. World J Gastroenterol. 2010;16(5):554-62. [PubMed ID: 20128022].

Similar Articles

3
Aug
2019

Sero-Prevalence of Hepatitis D Virus Infection Among Hepatitis B Surface Antigen Positive Patients in Mashhad, Northeastern Iran

Sanaz Ahmadi Ghezeldasht,
Mohammad Reza Hedayati-Moghaddam,
Arman Mosavat,
Mohammad Mehdi Akbarin
6
May
2017

Prevalence of Hepatitis D Virus Infection and Associated Factors Among HBsAg-Positive Patients in Birjand, Iran, 2012 - 2014

Gholamreza Sharifzadeh,
Mohammad Hasan Namaei,
Azadeh Ebrahimzadeh,
Zohreh Azarkar,
Mohammad Fereidouni,
Bita Bijari
,et al.
25
Aug
2013

Prevalence of Hepatitis D Virus Infection Among Patients With Chronic Hepatitis B Attending Birjand Hepatitis Clinic (East of Iran) in 2012

Masood Ziaee,
Ghodsieh Azarkar
27
Sep
2017

Prevalence of Hepatitis B Surface Antigen Among People Attending Medical Diagnostic Laboratories in Neyshabur, Northeast of Iran, During Years 2011 to 2015

Mohammad Salehi,
Somaye Najafi
20
Feb
2015

Distribution of Hepatitis Delta Virus Genotypes in Mashhad, Northeast Iran

Hamid Sadeghian,
Naiemeh Varasteh,
Abbas Esmaeelzadeh,
Hosein Nomani,
Maliheh Alimardani,
Mahdieh Davoodnejad
,et al.
Import into EndNoteImport into BibTex
Indexed in
logoWeb of Sciences Core Collections
Crossmark
Crossmark
Checking
Share on
Comments
Number of Comments:0
Cited by
Metrics
Licensing and reuse information

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles

Related Article in PubMed

Related Article in Google Scholar

Create Citation Alert via Google Reader